RUTH L KATZ to Antibody Specificity
This is a "connection" page, showing publications RUTH L KATZ has written about Antibody Specificity.
Connection Strength
0.009
-
Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial. Clin Cancer Res. 1997 Sep; 3(9):1547-55.
Score: 0.009